HomeIRMD • NASDAQ
Iradimed Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 19.51M | 10.87% |
Operating expense | 9.41M | 8.94% |
Net income | 4.69M | 13.32% |
Net profit margin | 24.02 | 2.17% |
Earnings per share | 0.42 | 16.67% |
EBITDA | 5.63M | 13.09% |
Effective tax rate | 21.16% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.33M | 11.53% |
Total assets | 101.73M | 15.58% |
Total liabilities | 11.68M | -1.83% |
Total equity | 90.05M | — |
Shares outstanding | 12.72M | — |
Price to book | 8.16 | — |
Return on assets | 13.57% | — |
Return on capital | 15.34% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 4.69M | 13.32% |
Cash from operations | 4.29M | 10.53% |
Cash from investing | -3.92M | -718.14% |
Cash from financing | -2.28M | 71.67% |
Net change in cash | -1.90M | 58.95% |
Free cash flow | -1.24M | 78.82% |
Previous close
$57.79
Year range
$41.69 - $63.29
Market cap
734.81M USD
Avg Volume
35.22K
P/E ratio
37.39
Dividend yield
1.18%
Primary exchange
NASDAQ
About
Founded
1992
Headquarters
Website
Employees
160
